Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma
- 1 July 2003
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 49 (1) , 35-49
- https://doi.org/10.1067/mjd.2003.449
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Prognostic factor analysis in mycosis fungoides/Sézary syndromeJournal of the American Academy of Dermatology, 1999
- Combined modality therapy for cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1996
- Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-upJournal of the American Academy of Dermatology, 1995
- Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoidsJournal of the American Academy of Dermatology, 1991
- Interferon alpha‐2a in cutaneous T‐cell lymphomaEuropean Journal of Haematology, 1990
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis FungoidesNew England Journal of Medicine, 1989
- Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Interferon alfa-2a in the treatment of cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987
- Combined total body electron beam irradiation and chemotherapy for mycosis fungoidesJournal of the American Academy of Dermatology, 1987